Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics Professional…
Hematology Today—December 8, 2025
This week in Hematology, we spotlight the most relevant updates, approvals, and…
Oncology Today—December 8, 2025
This week’s oncology roundup covers major advances in targeted therapy,…
Oncology Video Recap—December 8, 2025
Explore our biweekly Oncology video recap highlighting major regulatory wins,…
Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing
Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing Professional…
Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer Ventures
Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer…
Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+ NSCLC
Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+…
SABCS 2025 Preview: Key Breast Cancer Highlights to Watch
Get ready for SABCS25 with LucidQuest’s concise preview of the sessions…
Vaccines Today—December 5, 2025
This week’s vaccines update highlights key clinical findings, regulatory…
Respiratory Today—December 5, 2025
This week’s respiratory update highlights major developments across RSV…
Public Health Today—5 December, 2025
This Public Health weekly update highlights new evidence shaping behavioural,…
ASH 2025 Preview: Key Hematology Highlights to Watch
ASH 2025 at a glance Get ready for ASH 2025 with LucidQuest’s concise preview.…